{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:15:58Z","timestamp":1792977358441,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.10.035","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T10:04:42Z","timestamp":1513245882000},"page":"1397-1408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism"],"prefix":"10.1016","volume":"97","author":[{"given":"Yong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1753-0407.2012.00204.x","article-title":"Non-alcoholic fatty liver disease","volume":"4","author":"Tuyama","year":"2012","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Alimentary Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2017.10.035_bib0015","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.10.035_bib0025","first-page":"5","article-title":"TM6SF2 rs 58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2017.10.035_bib0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1152\/japplphysiol.01275.2013","article-title":"Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats","volume":"116","author":"Sheldon","year":"2014","journal-title":"J. Appl. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2017.10.035_bib0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.biopha.2017.10.035_bib0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimar\u00e3es","year":"2010","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.035_bib0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1872-034X.2011.00814.x","article-title":"Non-alcoholic steatohepatitis-induced fibrosis: toll-like receptors, reactive oxygen species and Jun N-terminal kinase","volume":"41","author":"Brenner","year":"2011","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0060","doi-asserted-by":"crossref","first-page":"e32785","DOI":"10.1371\/journal.pone.0032785","article-title":"Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD","volume":"7","author":"Pasar\u00edn","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3797\/scipharm.1104-21","article-title":"Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines","volume":"79","author":"Shams","year":"2011","journal-title":"Scientia Pharmaceutica"},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/liv.12531","article-title":"Hepatic toll\u2010like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD","volume":"35","author":"Vespasiani\u2010Gentilucci","year":"2015","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.saa.2010.04.009","article-title":"Interaction of alpinetin with bovine serum albumin: probing of the mechanism and binding site by spectroscopic methods","volume":"76","author":"Zhang","year":"2010","journal-title":"Spectrochim. Acta, Part A"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ijmm.2012.884","article-title":"Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells","volume":"29","author":"Du","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.intimp.2013.04.030","article-title":"Alpinetin attenuates inflammatory responses by interfering toll-like receptor 4\/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced mastitis in mice","volume":"17","author":"Chen","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2017.10.035_bib0090","first-page":"6","article-title":"Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis","author":"He","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.intimp.2011.11.017","article-title":"Traditional medicine alpinetin inhibits the inflammatory response in Raw 264.7 cells and mouse models","volume":"12","author":"Huo","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2017.10.035_bib0100","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.110.168815","article-title":"Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet","volume":"334","author":"Boini","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.035_bib0110","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance: dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ptr.3305","article-title":"Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress","volume":"25","author":"Liu","year":"2011","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0125","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/en.2009-1088","article-title":"Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet","volume":"151","author":"Drake","year":"2010","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1743-7075-8-65","article-title":"The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats","volume":"8","author":"Dhibi","year":"2011","journal-title":"Nutr. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2017.10.035_bib0135","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/liv.12379","article-title":"Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis","volume":"34","author":"Bambha","year":"2014","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jnutbio.2010.12.011","article-title":"Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver","volume":"23","author":"Ashino","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2017.10.035_bib0145","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2011.04065.x","article-title":"Obesity and psoriasis: body weight and body mass index influence the response to biological treatment","volume":"25","author":"Puig","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2017.10.035_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?","volume":"418","author":"Asrih","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3164\/jcbn.09-83","article-title":"A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 mice fed a high fat diet","volume":"46","author":"Fraulob","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.035_bib0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrgastro.2012.79","article-title":"Increased risk of cardiovascular disease and chronic kidney disease in NAFLD","volume":"9","author":"Bonora","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12072-015-9682-5","article-title":"Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol. Int."},{"issue":"12","key":"10.1016\/j.biopha.2017.10.035_bib0170","doi-asserted-by":"crossref","first-page":"e112346","DOI":"10.1371\/journal.pone.0112346","article-title":"Normocaloric low cholesterol diet modulates T\/Treg balance in patients with chronic hepatitis C virus infection","volume":"9","author":"Maggio","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.10.035_bib0175","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1440-1746.2009.06196.x","article-title":"Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver","volume":"25","author":"Kathirvel","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2013.05.014","article-title":"Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia: hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice","volume":"715","author":"Tahara","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.035_bib0185","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1039\/c1fo10133a","article-title":"The importance of the long-chain polyunsaturated fatty acid n-6\/n-3 ratio in development of non-alcoholic fatty liver associated with obesity","volume":"2","author":"Valenzuela","year":"2011","journal-title":"Food Function"},{"issue":"15","key":"10.1016\/j.biopha.2017.10.035_bib0190","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.clinbiochem.2010.07.022","article-title":"Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia","volume":"43","author":"Pirinccioglu","year":"2010","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.intimp.2015.08.002","article-title":"Alpinetin inhibits lipopolysaccharide-induced acute kidney injury in mice","volume":"28","author":"Huang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.035_bib0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2017.10.035_bib0205","first-page":"2015","article-title":"How inflammation impinges on NAFLD: a role for Kupffer cells","author":"Duarte","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2017.10.035_bib0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.nutr.012809.104755","article-title":"Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals","volume":"30","author":"Aggarwal","year":"2010","journal-title":"Annu. Rev. Nutr."},{"issue":"38","key":"10.1016\/j.biopha.2017.10.035_bib0215","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.3748\/wjg.v16.i38.4762","article-title":"Fat: a matter of disturbance for the immune system","volume":"16","author":"Federico","year":"2010","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.biopha.2017.10.035_bib0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","article-title":"Resveratrol mitigates lipopolysaccharide-and A(-mediated microglial inflammation by inhibiting the TLR4\/NF-(B\/STAT signaling cascade","volume":"120","author":"Capiralla","year":"2012","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0230","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jpi.12085","article-title":"Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4\/NF-(B system in high-fat-fed rabbits","volume":"55","author":"Hu","year":"2013","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00109-011-0807-6","article-title":"Involvement of TNF\u03b1-induced TLR4\u2013NF-\u03baB and TLR4\u2013HIF-\u03b1 feed-forward loops in the regulation of inflammatory responses in glioma","volume":"90","author":"Tewari","year":"2012","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0240","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.immuni.2014.01.013","article-title":"Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-(B signaling and protects against endotoxin shock","volume":"40","author":"Zhang","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biopha.2017.10.035_bib0245","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/ijmm.2013.1331","article-title":"Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4\/NF-(B pathway in BV-2 murine microglial cells","volume":"31","author":"Hu","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2013.09.049","article-title":"Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-(in THP-1-derived macrophages","volume":"721","author":"Hu","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.035_bib0255","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2004-1024","article-title":"Insulin resistance: the metabolic syndrome, and nonalcoholic fatty liver disease","volume":"90","author":"Angelico","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.biopha.2017.10.035_bib0260","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl\u2013CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.035_bib0265","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/jf802867b","article-title":"Compound K: intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells","volume":"57","author":"Kim","year":"2009","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.035_bib0270","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.035_bib0275","first-page":"603","article-title":"Impact of cholesterol metabolism and the LXR(-SREBP-1c pathway on nonalcoholic fatty liver disease","volume":"23","author":"Nakamuta","year":"2009","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.035_bib0280","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s000110050622","article-title":"Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation","volume":"49","author":"Chinetti","year":"2000","journal-title":"Inflam. Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.035_bib0285","doi-asserted-by":"crossref","first-page":"e0179135","DOI":"10.1371\/journal.pone.0179135","article-title":"Association of maternal weight with FADS and ELOVL genetic variants and fatty acid levels-The PREOBE follow-up","volume":"12","author":"de la Garza Puentes","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.10.035_bib0290","first-page":"1","article-title":"Impairment of systemic DHA synthesis affects macrophage plasticity and polarization: implications for DHA supplementation during inflammation","author":"Talamonti","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.035_bib0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10126-009-9179-0","article-title":"Highly unsaturated fatty acid synthesis in Atlantic salmon: characterization of ELOVL5-and ELOVL2-like elongases","volume":"11","author":"Morais","year":"2009","journal-title":"Marine Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.035_bib0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.biopha.2017.10.035_bib0305","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/cancers8080076","article-title":"Epigenetic activation of wnt\/(-Catenin signaling in NAFLD-Associated hepatocarcinogenesis","volume":"8","author":"Tian","year":"2016","journal-title":"Cancers"},{"issue":"6116","key":"10.1016\/j.biopha.2017.10.035_bib0310","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1227568","article-title":"JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation","volume":"339","author":"Han","year":"2013","journal-title":"Science"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217341367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217341367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:18:24Z","timestamp":1780337904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217341367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":62,"alternative-id":["S0753332217341367"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.035","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}